ArticleIndian journal of ophthalmology2011
Management of angle closure glaucoma.
Article in Indian journal of ophthalmology, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
15 citing papers in PubMed, 2 syntheses or guidelines pooled it.
- Iridotomy to slow progression of visual field loss in angle-closure glaucoma.The Cochrane database of systematic reviews · 2023Pooled it
- Iridotomy to slow progression of visual field loss in angle-closure glaucoma.The Cochrane database of systematic reviews · 2018Pooled it
- Clinical Observation of Laser Peripheral Iridoplasty with Number of Laser Shots in the Treatment of Acute Angle-Closure Glaucoma.Journal of healthcare engineering · 2022Trial
- Review
- Efficacy of Netarsudil in Open and Closed Angle Glaucomas Within the Vietnamese Population: A Single-Center, Retrospective Study.Clinical ophthalmology (Auckland, N.Z.) · 2026Article
- Visco-circumferential-suture-trabeculotomy-synechiolysis with phacoemulsification versus phacoemulsification alone for chronic primary angle closure glaucoma.BMC ophthalmology · 2025Article
- Resveratrol Alleviates Retinal Ischemia-Reperfusion Injury by Inhibiting the NLRP3/Gasdermin D/Caspase-1/Interleukin-1β Pyroptosis Pathway.Investigative ophthalmology & visual science · 2023Article
- Lowering of intraocular pressure after phacoemulsification in primary open-angle and angle-closure glaucoma: Correlation with lens thickness.Indian journal of ophthalmology · 2022Observational
- NLRP12 collaborates with NLRP3 and NLRC4 to promote pyroptosis inducing ganglion cell death of acute glaucoma.Molecular neurodegeneration · 2020Article
- Pentacam could be a useful tool for evaluating and qualifying the anterior chamber morphology.International journal of clinical and experimental medicine · 2014Article
- The timing of goniosynechialysis in treatment of primary angle-closure glaucoma combined with cataract.Molecular vision · 2012Article
- Drug-induced Acute Angle-closure Glaucoma: A Review.Journal of current glaucoma practiceReview
- Iridotomy to slow progression of angle-closure glaucoma.The Cochrane database of systematic reviewsArticle
- Primary angle-closure glaucoma: A retrospective interventional case series in South India.Oman journal of ophthalmologyArticle
- Role of Laser Iridoplasty in the Management of Angle Closure Mechanisms other than Pupillary Block.Journal of current glaucoma practiceArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Primary angle closure glaucoma (PACG) is equally prevalent in Indian in Asian population as the primary open angle glaucoma. Eighty-six percent of people with PACG are in Asia, with approximately 48.0% in China, 23.9% in India and 14.1% in southeast Asia. To understand PACG, it is mandatory to understand its classification and type of presentation with the underlying pathophysiology. The treatment options are medical, laser and/or surgical. The present article provides an overview of PACG.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.